GB-007

About Geneva Biotech

Geneva Biotech is a privately held, platform-focused biotech company developing advanced DNA delivery technologies for gene therapy and complex cell engineering applications. Its core expertise lies in engineering viral vectors to overcome cargo size limitations and target difficult cell and organ types. The company utilizes its platforms both for internal drug discovery programs, as evidenced by its preclinical candidate GB-007, and for providing research tools and services to academic and industrial partners. With a seasoned leadership team and a foundation in cutting-edge viral vector engineering, Geneva Biotech is positioned at the intersection of gene delivery technology and therapeutic development.